| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2009-01-12 |
4 |
S |
$14.00 |
$15,681 |
D/D |
(1,120) |
218,710 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2008-09-22 |
4 |
S |
$15.30 |
$17,597 |
D/D |
(1,150) |
332,312 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2008-09-22 |
4 |
S |
$15.30 |
$17,276 |
D/D |
(1,129) |
244,143 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2008-09-22 |
4 |
S |
$15.30 |
$21,361 |
D/D |
(1,396) |
219,830 |
|
- |
|
| Bloem James H |
Director |
– • – |
2008-03-13 |
4 |
B |
$16.39 |
$40,998 |
D/D |
2,500 |
5,000 |
2.39 |
- |
|
| Burgstahler David F |
Director |
– • – |
2008-03-07 |
4 |
B |
$15.65 |
$156,500 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2008-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
11,090 |
333,462 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2008-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
11,650 |
244,472 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2008-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
11,090 |
245,272 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2008-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,200 |
221,226 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2007-09-24 |
4 |
S |
$17.45 |
$24,576 |
D/D |
(1,408) |
209,026 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2007-09-24 |
4 |
S |
$17.45 |
$20,247 |
D/D |
(1,160) |
234,182 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2007-09-24 |
4 |
S |
$17.45 |
$20,247 |
D/D |
(1,160) |
322,372 |
|
- |
|
| Burgstahler David F |
Director |
– • – |
2007-03-12 |
4 |
B |
$14.77 |
$147,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Alpinvest Partners Later Stage Co-Investments Cust |
10% Owner |
– – • |
2006-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,739,164 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2006-09-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
15,300 |
210,434 |
|
- |
|
| Reichel W Carl |
President, PharmaceuticalsOffi |
• – – |
2006-09-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
732,803 |
|
- |
|
| Bruno Anthony D |
Exec. V.P., Corp. DevelopmentO |
• – – |
2006-09-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
659,391 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFOOfficer |
• – – |
2006-09-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
754,245 |
|
- |
|
| Boissonneault Roger M |
CEO & PresidentOfficer |
• • – |
2006-09-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,828,192 |
|
- |
|
| Boissonneault Roger M |
CEO & PresidentOfficer |
• • – |
2006-09-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
403,186 |
|
- |
|
| Boissonneault Roger M |
CEO & PresidentOfficer |
• • – |
2006-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,022,788 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory AffairsOf |
• – – |
2006-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
195,134 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel.Of |
• – – |
2006-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
222,742 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec.Off |
• – – |
2006-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
217,522 |
|
- |
|
380 Records found
|
|
Page 14 of 16 |
|
|
